English
This article is from Indian Journal of Endocrinology and Metabolism , volume 16 . Abstract Elevated low density lipoprotein cholesterol (LDL) has been identified as one of the strongest correctable risk factors for cardiovascular disease in patients with diabetes. The reduction in cardiovascular events with pharmacological therapy aimed at LDL lowering is well documented in both primary prevention and secondary prevention. In this article, we review the evolving trend of aggressive LDL cholesterol lowering strategies.
Sign in with your free account to read, download EPUBs or listen.
Ebook · Low density Lipoprotein cholesterol target: Changing goal posts. · Bantwal, Ganapathi, George, Belinda · Internet Archive